66 KiB
66 KiB
| 1 | Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Subject | Subject Data Revision | Screen No. | Age | Age Unit | Gender | Visit | Visit Data Revision | Collected Time | Accession | Test Group | Test | Administrative Question | Value | Result Data Revision | Flags | Cancellation Reason | Comments | Range | Units |
| 3 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 4 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 5 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 6 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 7 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 8 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||||
| 9 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.8 | 0 - 6.2 | umol/L | ||||||||||
| 10 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Alkaline Phosphatase | 73 | 40 - 129 | U/L | ||||||||||
| 11 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | ALT (SGPT) | 17 | 5 - 48 | U/L | ||||||||||
| 12 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | AST (SGOT) | 22 | 8 - 40 | U/L | ||||||||||
| 13 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | GGT | 18 | 10 - 61 | U/L | ||||||||||
| 14 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | LDH | 164 | 53 - 234 | U/L | ||||||||||
| 15 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Urea Nitrogen | 5.1 | 1.4 - 8.6 | mmol/L | ||||||||||
| 16 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 89 | 40 - 110 | umol/L | ||||||||||
| 17 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Serum Glucose | 5.4 | 3.9 - 5.6 | mmol/L | ||||||||||
| 18 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Serum Uric Acid | 346 | 125 - 488 | umol/L | ||||||||||
| 19 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Calcium (EDTA) | 2.46 | 2.07 - 2.64 | mmol/L | ||||||||||
| 20 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Phosphorus | 1.01 | 0.71 - 1.65 | mmol/L | ||||||||||
| 21 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Total Protein | 75 | 61 - 84 | g/L | ||||||||||
| 22 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Albumin-BCG | 49 | 33 - 49 | g/L | ||||||||||
| 23 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Creatine Kinase | 206 | 39 - 308 | U/L | ||||||||||
| 24 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||||
| 25 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||||
| 26 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Serum Bicarbonate | 20.1 | 19.3 - 29.3 | mmol/L | ||||||||||
| 27 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||||
| 28 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CHEMISTRY PANEL | Magnesium | 0.85 | 0.66 - 1.07 | mmol/L | ||||||||||
| 29 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 103 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 30 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | FECAL COLLECTION D/T | Stool Collection Date | Y | 26-May-2026 | |||||||||||
| 31 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | FECAL COLLECTION D/T | Stool Collection Time | Y | 07:00 | |||||||||||
| 32 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 151 | 127 - 181 | g/L | ||||||||||
| 33 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.44 | 0.39 - 0.54 | |||||||||||
| 34 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.6 | 4.5 - 6.4 | TI/L | ||||||||||
| 35 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 33 | 26 - 34 | pg | ||||||||||
| 36 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 37 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 97 | H | 79 - 96 | fL | |||||||||
| 38 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.61 | 3.8 - 10.7 | GI/L | ||||||||||
| 39 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.81 | 1.96 - 7.23 | GI/L | ||||||||||
| 40 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.03 | 0.91 - 4.28 | GI/L | ||||||||||
| 41 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.50 | 0.12 - 0.92 | GI/L | ||||||||||
| 42 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.23 | 0 - 0.57 | GI/L | ||||||||||
| 43 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||||
| 44 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 50.0 | 40.5 - 75 | % | ||||||||||
| 45 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 36.1 | 15.4 - 48.5 | % | ||||||||||
| 46 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 8.9 | 2.6 - 10.1 | % | ||||||||||
| 47 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 4.0 | 0 - 6.8 | % | ||||||||||
| 48 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 2 | % | ||||||||||
| 49 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 283 | 140 - 400 | GI/L | ||||||||||
| 50 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 51 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 26-May-2026 | |||||||||||
| 52 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 09:05 | |||||||||||
| 53 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 26-May-2026 | |||||||||||
| 54 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 10:10 | |||||||||||
| 55 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 26-May-2026 | |||||||||||
| 56 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 09:05 | |||||||||||
| 57 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 26-May-2026 | |||||||||||
| 58 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 07:00 | |||||||||||
| 59 | CZ100132002 | Male | Induction Week 2 | May 26, 2026 9:05 AM | 6228398115 | SUBJECT HEIGHT (CM) | Height (cm) | Y | 196 | cm | ||||||||||
| 60 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | ANATOMICAL SITE | Anatomical Site | Y | 15-20cm from anal verge | |||||||||||
| 61 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 62 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 63 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 25-May-2026 | |||||||||||
| 64 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 09:05 | |||||||||||
| 65 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 66 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | INFLAMED AREA | Inflamed area? | |||||||||||||
| 67 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 68 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 12:00 | ||||||||||||
| 69 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 27-May-2026 | ||||||||||||
| 70 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 71 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 72 | CZ100132003 | Female | Biopsy | May 25, 2026 12:00 AM | 6228501732 | ULCERATED AREA | Is biopsy site ulcerated? | Yes | ||||||||||||
| 73 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Total Bilirubin | 5 | 3 - 21 | umol/L | ||||||||||
| 74 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.9 | 0 - 6.2 | umol/L | ||||||||||
| 75 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Alkaline Phosphatase | 77 | 40 - 129 | U/L | ||||||||||
| 76 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | ALT (SGPT) | 19 | 5 - 48 | U/L | ||||||||||
| 77 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | AST (SGOT) | 21 | 8 - 40 | U/L | ||||||||||
| 78 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | GGT | 16 | 10 - 61 | U/L | ||||||||||
| 79 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | LDH | 159 | 53 - 234 | U/L | ||||||||||
| 80 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Urea Nitrogen | 5.0 | 1.4 - 8.6 | mmol/L | ||||||||||
| 81 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 96 | 40 - 110 | umol/L | ||||||||||
| 82 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Serum Glucose | 5.0 | 3.9 - 5.6 | mmol/L | ||||||||||
| 83 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Serum Uric Acid | 342 | 125 - 488 | umol/L | ||||||||||
| 84 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Calcium (EDTA) | 2.48 | 2.07 - 2.64 | mmol/L | ||||||||||
| 85 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Phosphorus | 1.05 | 0.71 - 1.65 | mmol/L | ||||||||||
| 86 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Total Protein | 76 | 61 - 84 | g/L | ||||||||||
| 87 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Albumin-BCG | 49 | 33 - 49 | g/L | ||||||||||
| 88 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Creatine Kinase | 204 | 39 - 308 | U/L | ||||||||||
| 89 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||||
| 90 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||||
| 91 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Serum Bicarbonate | 21.8 | 19.3 - 29.3 | mmol/L | ||||||||||
| 92 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||||
| 93 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CHEMISTRY PANEL | Magnesium | 0.85 | 0.66 - 1.07 | mmol/L | ||||||||||
| 94 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 94 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 95 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | FECAL COLLECTION D/T | Stool Collection Date | Y | 12-May-2026 | |||||||||||
| 96 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | FECAL COLLECTION D/T | Stool Collection Time | Y | 08:50 | |||||||||||
| 97 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 154 | 127 - 181 | g/L | ||||||||||
| 98 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.44 | 0.39 - 0.54 | |||||||||||
| 99 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.6 | 4.5 - 6.4 | TI/L | ||||||||||
| 100 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 33 | 26 - 34 | pg | ||||||||||
| 101 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 102 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 96 | 79 - 96 | fL | ||||||||||
| 103 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.64 | 3.8 - 10.7 | GI/L | ||||||||||
| 104 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.04 | 1.96 - 7.23 | GI/L | ||||||||||
| 105 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.81 | 0.91 - 4.28 | GI/L | ||||||||||
| 106 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.59 | 0.12 - 0.92 | GI/L | ||||||||||
| 107 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.16 | 0 - 0.57 | GI/L | ||||||||||
| 108 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||||
| 109 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 53.9 | 40.5 - 75 | % | ||||||||||
| 110 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 32.0 | 15.4 - 48.5 | % | ||||||||||
| 111 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 10.4 | H | 2.6 - 10.1 | % | |||||||||
| 112 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.8 | 0 - 6.8 | % | ||||||||||
| 113 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.9 | 0 - 2 | % | ||||||||||
| 114 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 275 | 140 - 400 | GI/L | ||||||||||
| 115 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||||
| 116 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | LIPID PANEL | Direct HDL-C 4th Generation | 1.26 | 1.03 - 1.53 | mmol/L | ||||||||||
| 117 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | LIPID PANEL | Triglycerides (GPO) | 1.63 | 0.5 - 2.81 | mmol/L | ||||||||||
| 118 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | LIPID PANEL | Cholesterol (High Performance) | 4.71 | 3.31 - 6.1 | mmol/L | ||||||||||
| 119 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | LIPID PANEL | LDL Chol Friedewald 4th | 2.70 | 0 - 3.34 | mmol/L | ||||||||||
| 120 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | PA1 EEA-2? | Approved to use EEA-2? | No | ||||||||||||
| 121 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 12-May-2026 | |||||||||||
| 122 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 10:25 | |||||||||||
| 123 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 12-May-2026 | |||||||||||
| 124 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 11:30 | |||||||||||
| 125 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 12-May-2026 | |||||||||||
| 126 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 10:25 | |||||||||||
| 127 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | SM10/FECAL BMRKS COLL D/T | Stool Collection Date | Y | 12-May-2026 | |||||||||||
| 128 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | SM10/FECAL BMRKS COLL D/T | Stool Collection Time | Y | 08:50 | |||||||||||
| 129 | CZ100132002 | Male | Induction Week 0 | May 12, 2026 10:25 AM | 6228308224 | SUBJECT HEIGHT (CM) | Height (cm) | Y | 196 | cm | ||||||||||
| 130 | CZ100132003 | Female | Stool Pathogens | May 7, 2026 5:45 AM | 6227635150 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 131 | CZ100132003 | Female | Stool Pathogens | May 7, 2026 5:45 AM | 6227635150 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 132 | CZ100132003 | Female | Stool Pathogens | May 7, 2026 5:45 AM | 6227635150 | OVA AND PARASITES 1 | Concentrate Exam | No ova or parasites found | ||||||||||||
| 133 | CZ100132003 | Female | Stool Pathogens | May 7, 2026 5:45 AM | 6227635150 | OVA AND PARASITES 1 | Smear for Microsporidia | No Microsporidia seen. | ||||||||||||
| 134 | CZ100132003 | Female | Stool Pathogens | May 7, 2026 5:45 AM | 6227635150 | OVA AND PARASITES 1 | Modified acid-fast stain | No coccidian parasites seen | ||||||||||||
| 135 | CZ100132003 | Female | Stool Pathogens | May 7, 2026 5:45 AM | 6227635150 | OVA AND PARASITES 2 | Trichrome Smear | No ova or parasites found | ||||||||||||
| 136 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||||
| 137 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.1 | 0 - 6.2 | umol/L | ||||||||||
| 138 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Alkaline Phosphatase | 95 | 35 - 104 | U/L | ||||||||||
| 139 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | ALT (SGPT) | 16 | 4 - 43 | U/L | ||||||||||
| 140 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | AST (SGOT) | 22 | 8 - 40 | U/L | ||||||||||
| 141 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | GGT | 34 | 4 - 49 | U/L | ||||||||||
| 142 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | LDH | 151 | 53 - 234 | U/L | ||||||||||
| 143 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Urea Nitrogen | 2.8 | 1.4 - 8.6 | mmol/L | ||||||||||
| 144 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 68 | 31 - 101 | umol/L | ||||||||||
| 145 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Serum Glucose | 5.2 | 3.9 - 5.6 | mmol/L | ||||||||||
| 146 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Serum Uric Acid | 357 | 125 - 428 | umol/L | ||||||||||
| 147 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Calcium (EDTA) | 2.31 | 2.07 - 2.64 | mmol/L | ||||||||||
| 148 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Phosphorus | 1.09 | 0.71 - 1.65 | mmol/L | ||||||||||
| 149 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||||
| 150 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||||
| 151 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Creatine Kinase | 51 | 26 - 192 | U/L | ||||||||||
| 152 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||||
| 153 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Serum Potassium | 4.1 | 3.5 - 5.2 | mmol/L | ||||||||||
| 154 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Serum Bicarbonate | 23.1 | 19.3 - 29.3 | mmol/L | ||||||||||
| 155 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Serum Chloride | 106 | 94 - 112 | mmol/L | ||||||||||
| 156 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CHEMISTRY PANEL | Magnesium | 0.81 | 0.66 - 1.07 | mmol/L | ||||||||||
| 157 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 95 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 158 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | |||||||||||
| 159 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 160 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 133 | 116 - 164 | g/L | ||||||||||
| 161 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | 0.34 - 0.48 | |||||||||||
| 162 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.7 | 4.1 - 5.6 | TI/L | ||||||||||
| 163 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 28 | 26 - 34 | pg | ||||||||||
| 164 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 165 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 84 | 79 - 98 | fL | ||||||||||
| 166 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.91 | 3.8 - 10.7 | GI/L | ||||||||||
| 167 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.94 | 1.96 - 7.23 | GI/L | ||||||||||
| 168 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.35 | 0.91 - 4.28 | GI/L | ||||||||||
| 169 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.40 | 0.12 - 0.92 | GI/L | ||||||||||
| 170 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.13 | 0 - 0.57 | GI/L | ||||||||||
| 171 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.09 | 0 - 0.2 | GI/L | ||||||||||
| 172 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 71.5 | 40.5 - 75 | % | ||||||||||
| 173 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 19.5 | 15.4 - 48.5 | % | ||||||||||
| 174 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.8 | 2.6 - 10.1 | % | ||||||||||
| 175 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.9 | 0 - 6.8 | % | ||||||||||
| 176 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.3 | 0 - 2 | % | ||||||||||
| 177 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 271 | 140 - 400 | GI/L | ||||||||||
| 178 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 179 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Non-Reactive | Ref Rng :$Non Reactive | |||||||||||
| 180 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 181 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 182 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 183 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 184 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 185 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 186 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 187 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | |||||||||||
| 188 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |||||||||||
| 189 | CZ100132003 | Female | Screening | May 6, 2026 10:45 AM | 6227635141 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 190 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 191 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 192 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 193 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 194 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 195 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||||
| 196 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.6 | 0 - 6.2 | umol/L | ||||||||||
| 197 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Alkaline Phosphatase | 88 | 40 - 129 | U/L | ||||||||||
| 198 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | ALT (SGPT) | 36 | 5 - 48 | U/L | ||||||||||
| 199 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | AST (SGOT) | 30 | 8 - 40 | U/L | ||||||||||
| 200 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | GGT | 21 | 10 - 61 | U/L | ||||||||||
| 201 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | LDH | 172 | 53 - 234 | U/L | ||||||||||
| 202 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Urea Nitrogen | 6.2 | 1.4 - 8.6 | mmol/L | ||||||||||
| 203 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 71 | 40 - 110 | umol/L | ||||||||||
| 204 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Serum Glucose | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||||
| 205 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Serum Uric Acid | 297 | 125 - 488 | umol/L | ||||||||||
| 206 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Calcium (EDTA) | 2.45 | 2.07 - 2.64 | mmol/L | ||||||||||
| 207 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Phosphorus | 1.22 | 0.71 - 1.65 | mmol/L | ||||||||||
| 208 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Total Protein | 74 | 61 - 84 | g/L | ||||||||||
| 209 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Albumin-BCG | 48 | 33 - 49 | g/L | ||||||||||
| 210 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Creatine Kinase | 177 | 39 - 308 | U/L | ||||||||||
| 211 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||||
| 212 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||||
| 213 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Serum Bicarbonate | 26.7 | 19.3 - 29.3 | mmol/L | ||||||||||
| 214 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||||
| 215 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CHEMISTRY PANEL | Magnesium | 0.83 | 0.66 - 1.07 | mmol/L | ||||||||||
| 216 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 123 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 217 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | FECAL COLLECTION D/T | Stool Collection Date | Y | 21-Apr-2026 | |||||||||||
| 218 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | FECAL COLLECTION D/T | Stool Collection Time | Y | 06:20 | |||||||||||
| 219 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 152 | 127 - 181 | g/L | ||||||||||
| 220 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.43 | 0.39 - 0.54 | |||||||||||
| 221 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.9 | 4.5 - 6.4 | TI/L | ||||||||||
| 222 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 31 | 26 - 34 | pg | ||||||||||
| 223 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | Normocytic | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 224 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 96 | fL | ||||||||||
| 225 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.31 | 3.8 - 10.7 | GI/L | ||||||||||
| 226 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 1.98 | 1.96 - 7.23 | GI/L | ||||||||||
| 227 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.64 | 0.91 - 4.28 | GI/L | ||||||||||
| 228 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.30 | 0.12 - 0.92 | GI/L | ||||||||||
| 229 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.30 | 0 - 0.57 | GI/L | ||||||||||
| 230 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.09 | 0 - 0.2 | GI/L | ||||||||||
| 231 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 46.0 | 40.5 - 75 | % | ||||||||||
| 232 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 38.0 | 15.4 - 48.5 | % | ||||||||||
| 233 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.0 | 2.6 - 10.1 | % | ||||||||||
| 234 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 7.0 | H | 0 - 6.8 | % | |||||||||
| 235 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 2.0 | 0 - 2 | % | ||||||||||
| 236 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 226 | 140 - 400 | GI/L | ||||||||||
| 237 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 238 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 21-Apr-2026 | |||||||||||
| 239 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 08:45 | |||||||||||
| 240 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 21-Apr-2026 | |||||||||||
| 241 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 09:50 | |||||||||||
| 242 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 21-Apr-2026 | |||||||||||
| 243 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 08:45 | |||||||||||
| 244 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 21-Apr-2026 | |||||||||||
| 245 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 06:20 | |||||||||||
| 246 | CZ100132001 | Male | Induction Week 4 | Apr 21, 2026 8:45 AM | 6227635146 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 247 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | ANATOMICAL SITE | Anatomical Site | Y | 15-20cm from anal verge | |||||||||||
| 248 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 249 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 250 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 21-Apr-2026 | |||||||||||
| 251 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 08:45 | |||||||||||
| 252 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 253 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | INFLAMED AREA | Inflamed area? | Yes | ||||||||||||
| 254 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 255 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 12:00 | ||||||||||||
| 256 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 23-Apr-2026 | ||||||||||||
| 257 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 258 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 259 | CZ100132002 | Male | Biopsy | Apr 21, 2026 12:00 AM | 6227635159 | ULCERATED AREA | Is biopsy site ulcerated? | Yes | ||||||||||||
| 260 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 261 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 262 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 263 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 264 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 265 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||||
| 266 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.8 | 0 - 6.2 | umol/L | ||||||||||
| 267 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Alkaline Phosphatase | 87 | 40 - 129 | U/L | ||||||||||
| 268 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | ALT (SGPT) | 27 | 5 - 48 | U/L | ||||||||||
| 269 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | AST (SGOT) | 25 | 8 - 40 | U/L | ||||||||||
| 270 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | GGT | 14 | 10 - 61 | U/L | ||||||||||
| 271 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | LDH | 174 | 53 - 234 | U/L | ||||||||||
| 272 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Urea Nitrogen | 5.5 | 1.4 - 8.6 | mmol/L | ||||||||||
| 273 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 87 | 40 - 110 | umol/L | ||||||||||
| 274 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Serum Glucose | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||||
| 275 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Serum Uric Acid | 299 | 125 - 488 | umol/L | ||||||||||
| 276 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Calcium (EDTA) | 2.44 | 2.07 - 2.64 | mmol/L | ||||||||||
| 277 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Phosphorus | 1.17 | 0.71 - 1.65 | mmol/L | ||||||||||
| 278 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Total Protein | 73 | 61 - 84 | g/L | ||||||||||
| 279 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Albumin-BCG | 49 | 33 - 49 | g/L | ||||||||||
| 280 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Creatine Kinase | 177 | 39 - 308 | U/L | ||||||||||
| 281 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||||
| 282 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||||
| 283 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Serum Bicarbonate | 26.5 | 19.3 - 29.3 | mmol/L | ||||||||||
| 284 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||||
| 285 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CHEMISTRY PANEL | Magnesium | 0.79 | 0.66 - 1.07 | mmol/L | ||||||||||
| 286 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 107 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 287 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | FECAL COLLECTION D/T | Stool Collection Date | Y | 07-Apr-2026 | |||||||||||
| 288 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | FECAL COLLECTION D/T | Stool Collection Time | Y | 06:30 | |||||||||||
| 289 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 150 | 127 - 181 | g/L | ||||||||||
| 290 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.45 | 0.39 - 0.54 | |||||||||||
| 291 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.9 | 4.5 - 6.4 | TI/L | ||||||||||
| 292 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 31 | 26 - 34 | pg | ||||||||||
| 293 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 294 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | 79 - 96 | fL | ||||||||||
| 295 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.89 | 3.8 - 10.7 | GI/L | ||||||||||
| 296 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.33 | 1.96 - 7.23 | GI/L | ||||||||||
| 297 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.84 | 0.91 - 4.28 | GI/L | ||||||||||
| 298 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.25 | 0.12 - 0.92 | GI/L | ||||||||||
| 299 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.37 | 0 - 0.57 | GI/L | ||||||||||
| 300 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.09 | 0 - 0.2 | GI/L | ||||||||||
| 301 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 47.7 | 40.5 - 75 | % | ||||||||||
| 302 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 37.7 | 15.4 - 48.5 | % | ||||||||||
| 303 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.2 | 2.6 - 10.1 | % | ||||||||||
| 304 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 7.7 | R | H | 0 - 6.8 | % | ||||||||
| 305 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.8 | 0 - 2 | % | ||||||||||
| 306 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 217 | 140 - 400 | GI/L | ||||||||||
| 307 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 308 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 07-Apr-2026 | |||||||||||
| 309 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 08:50 | |||||||||||
| 310 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 07-Apr-2026 | |||||||||||
| 311 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 10:00 | |||||||||||
| 312 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 07-Apr-2026 | |||||||||||
| 313 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 08:50 | |||||||||||
| 314 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 07-Apr-2026 | |||||||||||
| 315 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 06:30 | |||||||||||
| 316 | CZ100132001 | Male | Induction Week 2 | Apr 7, 2026 8:50 AM | 6227635144 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 317 | CZ100132002 | Male | Stool Pathogens | Apr 1, 2026 8:30 AM | 6227635148 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 318 | CZ100132002 | Male | Stool Pathogens | Apr 1, 2026 8:30 AM | 6227635148 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 319 | CZ100132002 | Male | Stool Pathogens | Apr 1, 2026 8:30 AM | 6227635148 | OVA AND PARASITES 1 | Concentrate Exam | No ova or parasites found | ||||||||||||
| 320 | CZ100132002 | Male | Stool Pathogens | Apr 1, 2026 8:30 AM | 6227635148 | OVA AND PARASITES 1 | Smear for Microsporidia | No Microsporidia seen. | ||||||||||||
| 321 | CZ100132002 | Male | Stool Pathogens | Apr 1, 2026 8:30 AM | 6227635148 | OVA AND PARASITES 1 | Modified acid-fast stain | No coccidian parasites seen | ||||||||||||
| 322 | CZ100132002 | Male | Stool Pathogens | Apr 1, 2026 8:30 AM | 6227635148 | OVA AND PARASITES 2 | Trichrome Smear | No ova or parasites found | ||||||||||||
| 323 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||||
| 324 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.5 | 0 - 6.2 | umol/L | ||||||||||
| 325 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Alkaline Phosphatase | 69 | 40 - 129 | U/L | ||||||||||
| 326 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | ALT (SGPT) | 20 | 5 - 48 | U/L | ||||||||||
| 327 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | AST (SGOT) | 18 | 8 - 40 | U/L | ||||||||||
| 328 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | GGT | 15 | 10 - 61 | U/L | ||||||||||
| 329 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | LDH | 130 | 53 - 234 | U/L | ||||||||||
| 330 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Urea Nitrogen | 6.0 | 1.4 - 8.6 | mmol/L | ||||||||||
| 331 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 82 | 40 - 110 | umol/L | ||||||||||
| 332 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Serum Glucose | 7.1 | H | 3.9 - 5.6 | mmol/L | |||||||||
| 333 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Serum Uric Acid | 301 | 125 - 488 | umol/L | ||||||||||
| 334 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Calcium (EDTA) | 2.45 | 2.07 - 2.64 | mmol/L | ||||||||||
| 335 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Phosphorus | 1.42 | 0.71 - 1.65 | mmol/L | ||||||||||
| 336 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Total Protein | 66 | 61 - 84 | g/L | ||||||||||
| 337 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||||
| 338 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Creatine Kinase | 91 | 39 - 308 | U/L | ||||||||||
| 339 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||||
| 340 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||||
| 341 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Serum Bicarbonate | 22.2 | 19.3 - 29.3 | mmol/L | ||||||||||
| 342 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||||
| 343 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CHEMISTRY PANEL | Magnesium | 0.75 | 0.66 - 1.07 | mmol/L | ||||||||||
| 344 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 114 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 345 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 346 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 147 | 127 - 181 | g/L | ||||||||||
| 347 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.41 | 0.39 - 0.54 | |||||||||||
| 348 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.3 | R | L | 4.5 - 6.4 | TI/L | ||||||||
| 349 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 34 | 26 - 34 | pg | ||||||||||
| 350 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 351 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 96 | 79 - 96 | fL | ||||||||||
| 352 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.60 | 3.8 - 10.7 | GI/L | ||||||||||
| 353 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.44 | 1.96 - 7.23 | GI/L | ||||||||||
| 354 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.11 | 0.91 - 4.28 | GI/L | ||||||||||
| 355 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.65 | 0.12 - 0.92 | GI/L | ||||||||||
| 356 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.28 | 0 - 0.57 | GI/L | ||||||||||
| 357 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.12 | 0 - 0.2 | GI/L | ||||||||||
| 358 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 58.4 | 40.5 - 75 | % | ||||||||||
| 359 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 27.8 | 15.4 - 48.5 | % | ||||||||||
| 360 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 8.6 | 2.6 - 10.1 | % | ||||||||||
| 361 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.7 | 0 - 6.8 | % | ||||||||||
| 362 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.5 | 0 - 2 | % | ||||||||||
| 363 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 256 | 140 - 400 | GI/L | ||||||||||
| 364 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 365 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Reactive | Ref Rng :$Non Reactive | |||||||||||
| 366 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 367 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 368 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 369 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 370 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 371 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 372 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 373 | CZ100132002 | Male | Screening | Apr 1, 2026 8:00 AM | 6227635139 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 374 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||||
| 375 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.4 | 0 - 6.2 | umol/L | ||||||||||
| 376 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Alkaline Phosphatase | 80 | 40 - 129 | U/L | ||||||||||
| 377 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | ALT (SGPT) | 24 | 5 - 48 | U/L | ||||||||||
| 378 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | AST (SGOT) | 19 | 8 - 40 | U/L | ||||||||||
| 379 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | GGT | 13 | 10 - 61 | U/L | ||||||||||
| 380 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | LDH | 166 | 53 - 234 | U/L | ||||||||||
| 381 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Urea Nitrogen | 7.7 | 1.4 - 8.6 | mmol/L | ||||||||||
| 382 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 89 | 40 - 110 | umol/L | ||||||||||
| 383 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Serum Glucose | 4.3 | 3.9 - 5.6 | mmol/L | ||||||||||
| 384 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Serum Uric Acid | 336 | 125 - 488 | umol/L | ||||||||||
| 385 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Calcium (EDTA) | 2.41 | 2.07 - 2.64 | mmol/L | ||||||||||
| 386 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Phosphorus | 1.04 | 0.71 - 1.65 | mmol/L | ||||||||||
| 387 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Total Protein | 72 | 61 - 84 | g/L | ||||||||||
| 388 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||||
| 389 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Creatine Kinase | 135 | 39 - 308 | U/L | ||||||||||
| 390 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||||
| 391 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||||
| 392 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Serum Bicarbonate | 22.2 | 19.3 - 29.3 | mmol/L | ||||||||||
| 393 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||||
| 394 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CHEMISTRY PANEL | Magnesium | 0.78 | 0.66 - 1.07 | mmol/L | ||||||||||
| 395 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 103 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 396 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | FECAL COLLECTION D/T | Stool Collection Date | Y | 24-Mar-2026 | |||||||||||
| 397 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | FECAL COLLECTION D/T | Stool Collection Time | Y | 07:30 | |||||||||||
| 398 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 156 | 127 - 181 | g/L | ||||||||||
| 399 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.46 | 0.39 - 0.54 | |||||||||||
| 400 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.1 | 4.5 - 6.4 | TI/L | ||||||||||
| 401 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 31 | 26 - 34 | pg | ||||||||||
| 402 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 403 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | 79 - 96 | fL | ||||||||||
| 404 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.53 | 3.8 - 10.7 | GI/L | ||||||||||
| 405 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.00 | 1.96 - 7.23 | GI/L | ||||||||||
| 406 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.61 | 0.91 - 4.28 | GI/L | ||||||||||
| 407 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.25 | 0.12 - 0.92 | GI/L | ||||||||||
| 408 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.57 | 0 - 0.57 | GI/L | ||||||||||
| 409 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.10 | 0 - 0.2 | GI/L | ||||||||||
| 410 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 54.3 | 40.5 - 75 | % | ||||||||||
| 411 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 29.0 | 15.4 - 48.5 | % | ||||||||||
| 412 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.6 | 2.6 - 10.1 | % | ||||||||||
| 413 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 10.4 | R | H | 0 - 6.8 | % | ||||||||
| 414 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.8 | 0 - 2 | % | ||||||||||
| 415 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 235 | 140 - 400 | GI/L | ||||||||||
| 416 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||||
| 417 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | LIPID PANEL | Direct HDL-C 4th Generation | 1.91 | H | 1.03 - 1.53 | mmol/L | |||||||||
| 418 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | LIPID PANEL | Triglycerides (GPO) | 0.67 | 0.5 - 2.81 | mmol/L | ||||||||||
| 419 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | LIPID PANEL | Cholesterol (High Performance) | 4.26 | 3.31 - 6.1 | mmol/L | ||||||||||
| 420 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | LIPID PANEL | LDL Chol Friedewald 4th | 2.04 | 0 - 3.34 | mmol/L | ||||||||||
| 421 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 422 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 24-Mar-2026 | |||||||||||
| 423 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 09:40 | R | ||||||||||
| 424 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 24-Mar-2026 | |||||||||||
| 425 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 10:45 | |||||||||||
| 426 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 24-Mar-2026 | |||||||||||
| 427 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 09:40 | R | ||||||||||
| 428 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | SM10/FECAL BMRKS COLL D/T | Stool Collection Date | Y | 24-Mar-2026 | |||||||||||
| 429 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | SM10/FECAL BMRKS COLL D/T | Stool Collection Time | Y | 07:30 | |||||||||||
| 430 | CZ100132001 | Male | Induction Week 0 | Mar 24, 2026 9:40 AM | 6227635142 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 431 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | ANATOMICAL SITE | Anatomical Site | Y | 15-20cm from anal verge | |||||||||||
| 432 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 433 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 434 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 12-Mar-2026 | |||||||||||
| 435 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 07:52 | |||||||||||
| 436 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 437 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | INFLAMED AREA | Inflamed area? | Yes | ||||||||||||
| 438 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 439 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 10:00 | ||||||||||||
| 440 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 14-Mar-2026 | ||||||||||||
| 441 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 442 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 443 | CZ100132001 | Male | Biopsy | Mar 12, 2026 12:00 AM | 6227635161 | ULCERATED AREA | Is biopsy site ulcerated? | No | ||||||||||||
| 444 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||||
| 445 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.7 | 0 - 6.2 | umol/L | ||||||||||
| 446 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Alkaline Phosphatase | 95 | 40 - 129 | U/L | ||||||||||
| 447 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | ALT (SGPT) | 25 | 5 - 48 | U/L | ||||||||||
| 448 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | AST (SGOT) | 16 | 8 - 40 | U/L | ||||||||||
| 449 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | GGT | 16 | 10 - 61 | U/L | ||||||||||
| 450 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | LDH | 149 | 53 - 234 | U/L | ||||||||||
| 451 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Urea Nitrogen | 7.1 | 1.4 - 8.6 | mmol/L | ||||||||||
| 452 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 89 | 40 - 110 | umol/L | ||||||||||
| 453 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Serum Glucose | 6.6 | H | 3.9 - 5.6 | mmol/L | |||||||||
| 454 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Serum Uric Acid | 358 | 125 - 488 | umol/L | ||||||||||
| 455 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Calcium (EDTA) | 2.32 | 2.07 - 2.64 | mmol/L | ||||||||||
| 456 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Phosphorus | 1.05 | 0.71 - 1.65 | mmol/L | ||||||||||
| 457 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Total Protein | 72 | 61 - 84 | g/L | ||||||||||
| 458 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||||
| 459 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Creatine Kinase | 100 | 39 - 308 | U/L | ||||||||||
| 460 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||||
| 461 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Serum Potassium | 3.8 | 3.5 - 5.2 | mmol/L | ||||||||||
| 462 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Serum Bicarbonate | 23.4 | 19.3 - 29.3 | mmol/L | ||||||||||
| 463 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||||
| 464 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CHEMISTRY PANEL | Magnesium | 0.75 | 0.66 - 1.07 | mmol/L | ||||||||||
| 465 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 103 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 466 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 467 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 154 | 127 - 181 | g/L | ||||||||||
| 468 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.45 | 0.39 - 0.54 | |||||||||||
| 469 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.0 | 4.5 - 6.4 | TI/L | ||||||||||
| 470 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 31 | 26 - 34 | pg | ||||||||||
| 471 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 472 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 96 | fL | ||||||||||
| 473 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.82 | 3.8 - 10.7 | GI/L | ||||||||||
| 474 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.88 | 1.96 - 7.23 | GI/L | ||||||||||
| 475 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.03 | 0.91 - 4.28 | GI/L | ||||||||||
| 476 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.26 | 0.12 - 0.92 | GI/L | ||||||||||
| 477 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.57 | 0 - 0.57 | GI/L | ||||||||||
| 478 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.08 | 0 - 0.2 | GI/L | ||||||||||
| 479 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 49.4 | 40.5 - 75 | % | ||||||||||
| 480 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 34.9 | 15.4 - 48.5 | % | ||||||||||
| 481 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.4 | 2.6 - 10.1 | % | ||||||||||
| 482 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 9.9 | H | 0 - 6.8 | % | |||||||||
| 483 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.4 | 0 - 2 | % | ||||||||||
| 484 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 222 | 140 - 400 | GI/L | ||||||||||
| 485 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 486 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Non-Reactive | Ref Rng :$Non Reactive | |||||||||||
| 487 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 488 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 489 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 490 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 491 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 492 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 493 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 494 | CZ100132001 | Male | Screening | Feb 26, 2026 1:20 PM | 6227635140 | SUBJECT HEIGHT (CM) | Height (cm) | Y | 163 | cm | ||||||||||
| 495 | CZ100132001 | Male | Stool Pathogens | Feb 26, 2026 10:35 AM | 6227635149 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 496 | CZ100132001 | Male | Stool Pathogens | Feb 26, 2026 10:35 AM | 6227635149 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 497 | CZ100132001 | Male | Stool Pathogens | Feb 26, 2026 10:35 AM | 6227635149 | OVA AND PARASITES 1 | Concentrate Exam | No ova or parasites found | ||||||||||||
| 498 | CZ100132001 | Male | Stool Pathogens | Feb 26, 2026 10:35 AM | 6227635149 | OVA AND PARASITES 1 | Smear for Microsporidia | No Microsporidia seen. | ||||||||||||
| 499 | CZ100132001 | Male | Stool Pathogens | Feb 26, 2026 10:35 AM | 6227635149 | OVA AND PARASITES 1 | Modified acid-fast stain | No coccidian parasites seen | ||||||||||||
| 500 | CZ100132001 | Male | Stool Pathogens | Feb 26, 2026 10:35 AM | 6227635149 | OVA AND PARASITES 2 | Trichrome Smear | No ova or parasites found |